Boston University School of Medicine, The Pulmonary Center, R-304, 715 Albany Street, Boston, MA 02118, USA.
Ann Am Thorac Soc. 2013 Feb;10(1):10-7. doi: 10.1513/AnnalsATS.201206-034OC.
Although evidence supporting use of noninvasive ventilation (NIV) during acute exacerbations of chronic obstructive pulmonary disease (COPD) is strong, evidence varies widely for other causes of acute respiratory failure.
To compare utilization trends and outcomes associated with NIV in patients with and without COPD.
We identified 11,659,668 cases of acute respiratory failure from the Nationwide Inpatient Sample during years 2000 to 2009 and compared NIV utilization trends and failure rates for cases with or without a diagnosis of COPD.
The proportion of patients with COPD who received NIV increased from 3.5% in 2000 to 12.3% in 2009 (250% increase), and the proportion of patients without COPD who received NIV increased from 1.2% in 2000 to 6.0% in 2009 (400% increase). The rate of increase in the use of NIV was significantly greater for patients without COPD (18.1% annual change) than for patients with COPD (14.3% annual change; P = 0.02). Patients without COPD were more likely to have failure of NIV requiring endotracheal intubation (adjusted odds ratio, 1.19; 95% confidence interval, 1.15-1.22; P < 0.0001). Patients in whom NIV failed had higher hospital mortality than patients receiving mechanical ventilation without a preceding trial of NIV (adjusted odds ratio, 1.14; 95% confidence interval, 1.11-1.17; P < 0.0001).
The use of NIV during acute respiratory failure has increased at a similar rate for all diagnoses, regardless of supporting evidence. However, NIV is more likely to fail in patients without COPD, and NIV failure is associated with increased mortality.
虽然有大量证据支持在慢性阻塞性肺疾病(COPD)急性加重期使用无创通气(NIV),但其他急性呼吸衰竭病因的证据差异很大。
比较有和无 COPD 的急性呼吸衰竭患者使用 NIV 的趋势和结局。
我们从 2000 年至 2009 年的全国住院患者样本中确定了 11659668 例急性呼吸衰竭病例,并比较了有和无 COPD 诊断的病例中 NIV 使用趋势和失败率。
有 COPD 的患者接受 NIV 的比例从 2000 年的 3.5%增加到 2009 年的 12.3%(增加了 250%),而无 COPD 的患者接受 NIV 的比例从 2000 年的 1.2%增加到 2009 年的 6.0%(增加了 400%)。无 COPD 的患者使用 NIV 的增长率明显大于有 COPD 的患者(18.1%的年增长率)(P=0.02)。无 COPD 的患者更有可能因 NIV 失败而需要气管插管(校正比值比,1.19;95%置信区间,1.15-1.22;P<0.0001)。NIV 失败的患者比未接受 NIV 试验的机械通气患者的院内死亡率更高(校正比值比,1.14;95%置信区间,1.11-1.17;P<0.0001)。
无论证据如何,所有诊断的急性呼吸衰竭患者使用 NIV 的比例都以相似的速度增加。然而,NIV 在无 COPD 的患者中更有可能失败,并且 NIV 失败与死亡率增加相关。